Joseph EdelmanVRDN history

Issuer:
VIRIDIAN THERAPEUTICS INC
Quarters tracked:
20 (Q2 2021Q1 2026)
Current shares:
1,170,829
Current value:
$22.90M
Peak shares:
3,657,099 (Q1 2024)
Overall change:
+47%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 20261,170,829$22.90M$19.56-1,871,874-62%
Q4 20253,042,703$94.69M$31.12+1,580,303+108%
Q3 20251,462,400$31.56M$21.58+1,014,893+227%
Q2 2025447,507$6.26M$13.98-212,155-32%
Q1 2025659,662$8.89M$13.48-826,846-56%
Q4 20241,486,508$28.50M$19.17-1,326,157-47%
Q3 20242,812,665$63.99M$22.75+1,180,837+72%
Q2 20241,631,828$21.23M$13.01-2,025,271-55%
Q1 20243,657,099$64.04M$17.51+1,926,887+111%
Q4 20231,730,212$37.68M$21.78+719,007+71%
Q3 20231,011,205$15.51M$15.34-765,181-43%
Q2 20231,776,386$42.26M$23.79+40,000+2%
Q1 20231,736,386$44.17M$25.44+515,811+42%
Q4 20221,220,575$35.65M$29.2100%
Q3 20221,220,575$25.03M$20.51+248,743+26%
Q2 2022971,832$11.24M$11.57-451,221-32%
Q1 20221,423,053$26.31M$18.4900%
Q4 20211,423,053$28.13M$19.77+530%
Q3 20211,423,000$23.41M$16.45+628,494+79%
Q2 2021794,506$14.53M$18.29NEW